Janet H Ransom Selected Research

4-O-carboxymethylascochlorin

12/2008

Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janet H Ransom Research Topics

Disease

1	Chills 01/2018
1	Fever (Fevers) 01/2018
1	Headache (Headaches) 01/2018
1	Hemorrhage 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Visceral Leishmaniasis (Kala Azar) 10/2013
1	Cutaneous Leishmaniasis 10/2013
1	Body Weight (Weight, Body) 10/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2008
1	Neoplasms (Cancer) 12/2008

Drug/Important Bio-Agent (IBA)

1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2018
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 10/2013
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 12/2008
1	Tumor Biomarkers (Tumor Markers)IBA 12/2008
1	4-O-carboxymethylascochlorinIBA 12/2008

Therapy/Procedure

1	Therapeutics 12/2008
1	Intravesical Administration 12/2008